Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline. Bourdin A, Virchow JC, Papi A, Lugogo NL, et al. Respir Med 2022;202:106938.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bourdin A, Virchow JC, Papi A, Lugogo NL, et al. Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline. Respir Med 2022;202:106938.
PMID: 36087550